Deficiencies in patients' comprehension of implantable cardioverter defibrillator therapy

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 9, 2012, Pages 1097-1102

  Groarke, John ^a   Beirne, Avril ^a   Buckley, Una ^a   O'Dwyer, Elisabeth ^a   Sugrue, Declan ^a   Keelan, Ted ^a   O'Neill, James ^a   Galvin, Joe ^a   Mahon, Niall ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

consent; ICD; patient comprehension; patient education

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BREATHING EXERCISE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPREHENSION; CONVULSIVE THERAPY; CROSS-SECTIONAL STUDY; DEFIBRILLATOR; DEVICE INFECTION; DEVICE REMOVAL; FEMALE; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PNEUMOTHORAX; QUESTIONNAIRE; RETROSPECTIVE STUDY; SHOCK; TELECONSULTATION; TERMINAL DISEASE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMED CONSENT; IRELAND; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; RETROSPECTIVE STUDIES;

EID: 84866180941     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03448.x     Document Type: Article

References (44)

1. Tung R, Zimetbaum P, Josephson M,. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008; 52: 1111-1121.
2. Scott PA, Gorman S, Andrews NP, Roberts PR, Kalra PR,. Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006). Europace 2008; 10: 453-457.
3. Goldberger Z, Lampert R,. Implantable cardioverter-defibrillators: Expanding indications and technologies. JAMA 2006; 29: 809-818.
4. http://www.eucomed.org/newsroom/41/19/Landmark-trial-concludes-that- Cardiac-Resynchronization-Therapy-CRT-combined-with-Implantable-cardioverter- defibrillator-ICD-reduces-the-risk-of-mortality-and-heart-failures [accessed June 6, 2012].
5. Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D, Greenspon AJ,. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol 2010; 33: 705-711.
6. Brown DW, Croft JB, Greenlund KJ, Mensah GA, Giles WH,. Trends in hospitalization for the implantation of cardioverter-defibrillators in the United States, 1990-2005. Am J Cardiol 2008; 101: 1753-1755.
7. Proclemer A, Ghidina M, Gregori D, Facchin D, Rebellato L, Fioretti P, Brignole M,. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: Data from the Italian ICD Registry for the years 2005-07. Europace 2009; 11: 465-475.
8. Berger J,. The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med 2005; 142: 631-634.
9. England R, England T, Coggon J,. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer. J Med Ethics 2007; 33: 538-540.
10. http://health.sjm.com/arrhythmia-answers/~/media/SJM%20Health/AA/PDF/ ICD%20patient%20manual.ashx (accessed March 5, 2012).
11. http://www.medtronic.com/wcm/groups/mdtcom-sg/@mdt/@crdm/documents/ documents/201102810enp32-prnt.pdf (accessed March 5, 2012).
12. http://www.biotronik.com/wps/wcm/connect/en-us-web/biotronik/sub-top/ patients/dianostics-and-therapies/defibrillators [accessed June 6, 2012].
13. http://www.medtronic.com/patients/sudden-cardiac-arrest/device/ questions-answers/index.htm (accessed March 5, 2012).
14. Demiris G,. Principles of survey development for telemedicine applications. J Telemed Telecare 2006; 12: 111-115.
15. Goldstein N, Bradley E, Zeidman J, Mehta D, Morrison RS,. Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol 2009; 54: 371-374
16. Khan MN, Joseph G, Khaykin Y, Ziada KM, Wilkoff BL,. Delayed lead perforation: A disturbing trend. Pacing Clin Electrophysiol 2005; 28: 251-253.
17. Kennergren C, Bjurman C, Wiklund R, Gäbel J,. A single-centre experience of over one thousand lead extractions. Europace 2009; 11: 612-627.
18. Faulknier BA, Traub DM, Aktas MK, Aguila A, Rosero S, Daubert JP, Hall B, et al,. Time-dependent risk of Fidelis lead failure. Am J Cardiol 2010; 105: 95-99.
19. Dunbar SB, Smith PF, Zhang XZ, Weintraub WS, Langberg JL, Leon AR,. ICD activations and quality of life one year after implant. Pacing Clin Electrophysiol 2001; 24: 162.
20. Kamphuis HC, de Leeuw JR, Derksen R, Hauer RN, Winnubst JA,. Implantable cardioverter defibrillator recipients: Quality of life in recipients with and without ICD shock delivery: A prospective study. Europace 2003; 5: 381-389.
21. Sears SE Jr, Conti JB,. Understanding implantable cardioverter defibrillator shocks and storms: Medical and psychosocial considerations for research and clinical care. Clin Cardiol 2003; 26: 107-111.
22. Thomas SA, Friedmann E, Kao CW, Inguito P, Metcalf M, Kelley FJ, Gottlieb SS,. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care 2006; 15: 389-398.
23. Agård A, Löfmark R, Edvardsson N, Ekman I,. Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: Prescription rather than participation. J Med Ethics 2007; 33: 514-518.
24. Lüderitz B, Wolpert C,. The patient's informed consent for pacemakers and ICD implantation: How to write and how to explain it. Z Kardiol 2003; 92: 377-383.
25. Fortun P, West J, Chalkley L, Shonde A, Hawkey C,. Recall of informed consent information by healthy volunteers in clinical trials. QJM 2008; 101: 625-629.
26. Bhutta ZA,. Beyond informed consent. Bull World Health Organ 2004; 82: 771-777.
27. Shurnas PS, Coughlin MJ,. Recall of the risks of forefoot surgery after informed consent. Foot Ankle Int 2003; 24: 904-908.
28. Flory J, Emanuel E,. Interventions to improve research participants' understanding in informed consent for research: A systematic review. JAMA 2004; 292: 1593-1601.
29. Schenker Y, Fernandez A, Sudore R, Schillinger D,. Interventions to improve patient comprehension in informed consent for medical and surgical procedures: A systematic review. Med Decis Making 2011; 31: 151-173.
30. Eggers C, Obliers R, Koerfer A, Thomas W, Koehle K, Hoelscher AH, Bollschweiler E,. A multimedia tool for the informed consent of patients prior to gastric banding. Obesity 2007; 15: 2866-2873.
31. Beamond BM, Beischer AD, Brodsky JW, Leslie H,. Improvement in surgical consent with a preoperative multimedia patient education tool: A pilot study. Foot Ankle Int 2009; 30: 619-626.
32. Marijon E, Trinquart L, Otmani A, Leclercq C, Fauchier L, Chevalier P, Klug D, et al,. Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator-the EVADEF study. Am Heart J 2010; 159: 659-664.
33. McCready MJ, Exner DV,. Quality of life and psychological impact of implantable cardioverter defibrillators: Focus on randomized controlled trial data. Card Electrophysiol Rev 2003; 7: 63-70.
34. Withell B,. Patient consent and implantable cardioverter defibrillators: Some palliative care implications. Int J Palliative Nursing 2006; 12: 470-475
35. Goldstein NE, Mehta D, Siddiqui S, Teitelbaum E, Zeidman J, Singson M, Pe E, et al,. "That's like an act of suicide": Patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med 2008; 23 (Suppl. 1): 7-12.
36. Goldstein N, Carlson M, Livote E, Kutner JS,. Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey. Ann Intern Med 2010; 152: 296-299.
37. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM,. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004; 141: 835-838.
38. Kelley AS, Mehta SS, Reid MC,. Management of patients with ICDs at the End of Life (EOL): A qualitative study. Am J Hosp Palliat Care 2009; 25: 440-446.
39. Hauptman PJ,. Palliation in heart failure: When less and more are more. Am J Hosp Palliat Care 2006; 23: 150-152.
40. Morrison LJ, Sinclair CT,. Next-of-kin responses and do-not-resuscitate implications for implantable cardioverter defibrillators. Ann Intern Med 2005; 142: 676-677.
41. Bramstedt KA, Mueller PS,. Management of implantable cardioverter defibrillators in end-of-life care: A reply [electronic letter]. Ann Intern Med 2004 Dec.
42. Gabbott D, Smith G, Mitchell S, Colquhoun M, Nolan J, Soar J, Pitcher D, et al,. Royal College of Anaesthetists; Royal College of Physicians of London; Intensive Care Society; Resuscitation Council. Cardiopulmonary resuscitation standards for clinical practice and training in the UK. Resuscitation 2005; 64: 13-19.
43. Field JM, Hazinski MF, Sayre MR, Chameides L, Schexnayder SM, Hemphill R, Samson RA, et al,. Part 1: Executive summary: 2010 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2010; 122 (18 Suppl. 3): S640-S656.
44. Sherazi S, Daubert JP, Block RC, Jeevanantham V, Abdel-Gadir K, Disalle MR, Haley JM, et al,. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc 2008; 83: 1139-1141.